KIF11 and small cell lung carcinoma: Genetic and pharmacologic inhibition of Eg5 arrested SCLC cells in the G2/M phase of the cell cycle and induced potent cytotoxicity in vitro, establishing Eg5 as a dependency in several SCLC cell lines [60,68].